Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study

R. Ratner, M. Nauck, C. Kapitza, V. Asnaghi, M. Boldrin and R. Balena

Diabetic Medicine 27 ( 5 ): 556 - 562 , 2010